Lista de obras - Svetlana Gelperina - Dominio Público Uruguay

Adsorption of plasma proteins on uncoated PLGA nanoparticles.

artículo científico publicado en 2013

Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation

artículo científico publicado en 2014

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

artículo científico publicado en 2006

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

artículo científico publicado en 2009

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants

artículo científico publicado en 2006

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles

artículo científico publicado en 2004

Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging

artículo científico publicado en 2012

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

artículo científico publicado en 2006

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.

artículo científico publicado en 2006

Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells.

artículo científico publicado en 2017

Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging

artículo científico publicado en 2014

Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI.

artículo científico publicado en 2013

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

artículo científico publicado en 2003

Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers

artículo científico publicado en 2011

Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects

artículo científico publicado en 2009

Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis

artículo científico publicado en 2007

Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles

artículo científico publicado en 2009

Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

artículo científico publicado en 2006

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity

article

Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats

artículo científico publicado en 2008

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

scientific article published on 16 May 2011

Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.

artículo científico publicado en 2017

Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles

artículo científico publicado en 2008

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

artículo científico publicado en 1999

Simultaneous determination of rifabutin and human serum albumin in pharmaceutical formulations by capillary electrophoresis.

artículo científico publicado en 2017

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

artículo científico publicado en 2002

Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma

artículo científico publicado en 2018

Transferrin-coated gadolinium nanoparticles as MRI contrast agent

artículo científico publicado en 2013

Transport of drugs across the blood-brain barrier by nanoparticles.

artículo científico publicado en 2011

Use of nanoparticles for cerebral cancer.

artículo científico publicado en 2008

Lista de obras de Svetlana Gelperina

Adsorption of plasma proteins on uncoated PLGA nanoparticles.

Arylsulfatase A bound to poly(butyl cyanoacrylate) nanoparticles for enzyme replacement therapy--physicochemical evaluation

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles

Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays.

Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells.

Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging

Development of nanoparticle-bound arylsulfatase B for enzyme replacement therapy of mucopolysaccharidosis VI.

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers

Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects

Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis

Encapsulation of water-insoluble drugs in poly(butyl cyanoacrylate) nanoparticles

Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity

Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.

Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

Simultaneous determination of rifabutin and human serum albumin in pharmaceutical formulations by capillary electrophoresis.

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma

Transferrin-coated gadolinium nanoparticles as MRI contrast agent

Transport of drugs across the blood-brain barrier by nanoparticles.

Use of nanoparticles for cerebral cancer.